Skip to main content

Dogwood Therapeutics, Inc.

DWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001818844

No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.

Superinvestors holding DWTX, Q2 2026

See all superinvestors

No superinvestor reported holding DWTX in Q2 2026.